Immunotherapy Therapy

DRUG3 trials

Sponsors

Zhongnan Hospital, Three Gorges Hospital of Chongqing University, Nanfang Hospital, Southern Medical University

Conditions

Breast Cancer, Metastatic Breast CancerEsophageal Squamous Cell Carcinoma (ESCC)Malignant Tumors

Phase 1

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

Enrolling by invitationNCT06890871

Zhongnan HospitalBreast Cancer, Metastatic Breast Cancer

Start: 2024-08-08End: 2025-12-31Target: 25Updated: 2025-03-24

Unknown Phase

An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

RecruitingNCT07080437

Three Gorges Hospital of Chongqing UniversityEsophageal Squamous Cell Carcinoma (ESCC)

Start: 2021-03-01End: 2026-11-01Target: 40Updated: 2025-07-23

Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis

RecruitingNCT07622667

Nanfang Hospital, Southern Medical UniversityMalignant Tumors

Start: 2026-05-29End: 2027-06-30Target: 500Updated: 2026-06-03